Protein Design Labs, Inc.

Net loss reported by developer of humanized antibodies

Published in Pharma Law Weekly, June 1st, 2004

Protein Design Labs, Inc., (PDL) reported a net loss of $12.6 million, or $0.13 per basic and diluted share, for the 3 months ended March 31, 2004, compared with net income of $4.1 million, or $0.05 per basic and diluted share, for the 3 months ended March 31, 2003.

Excluding certain non-cash charges, the non-GAAP net loss in the first quarter of 2004 would have been $12.0 million, or $0.13 per basic and diluted share.

On March 31, 2004, PDL had cash, cash equivalents, marketable securities and restricted investments totaling approximately $466.9 million, compared with $505.0 million at December 31, 2003.

The March 31, 2004...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Pharma Law Weekly

Source: Pharma Law Weekly (2004-06-01)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry